306 related articles for article (PubMed ID: 26347530)
1. Biomarkers for bile acid diarrhoea in functional bowel disorder with diarrhoea: a systematic review and meta-analysis.
Valentin N; Camilleri M; Altayar O; Vijayvargiya P; Acosta A; Nelson AD; Murad MH
Gut; 2016 Dec; 65(12):1951-1959. PubMed ID: 26347530
[TBL] [Abstract][Full Text] [Related]
2. SeHCAT [tauroselcholic (selenium-75) acid] for the investigation of bile acid malabsorption and measurement of bile acid pool loss: a systematic review and cost-effectiveness analysis.
Riemsma R; Al M; Corro Ramos I; Deshpande SN; Armstrong N; Lee YC; Ryder S; Noake C; Krol M; Oppe M; Kleijnen J; Severens H
Health Technol Assess; 2013 Dec; 17(61):1-236. PubMed ID: 24351663
[TBL] [Abstract][Full Text] [Related]
3. Performance characteristics of serum C4 and FGF19 measurements to exclude the diagnosis of bile acid diarrhoea in IBS-diarrhoea and functional diarrhoea.
Vijayvargiya P; Camilleri M; Carlson P; Lueke A; O'Neill J; Burton D; Busciglio I; Donato L
Aliment Pharmacol Ther; 2017 Sep; 46(6):581-588. PubMed ID: 28691284
[TBL] [Abstract][Full Text] [Related]
4. Bile and fat excretion are biomarkers of clinically significant diarrhoea and constipation in irritable bowel syndrome.
Vijayvargiya P; Camilleri M; Burton D; Busciglio I; Lueke A; Donato LJ
Aliment Pharmacol Ther; 2019 Mar; 49(6):744-758. PubMed ID: 30740753
[TBL] [Abstract][Full Text] [Related]
5. AGA Technical Review on the Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults (IBS-D).
Carrasco-Labra A; Lytvyn L; Falck-Ytter Y; Surawicz CM; Chey WD
Gastroenterology; 2019 Sep; 157(3):859-880. PubMed ID: 31351880
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factor 19 in patients with bile acid diarrhoea: a prospective comparison of FGF19 serum assay and SeHCAT retention.
Pattni SS; Brydon WG; Dew T; Johnston IM; Nolan JD; Srinivas M; Basumani P; Bardhan KD; Walters JR
Aliment Pharmacol Ther; 2013 Oct; 38(8):967-76. PubMed ID: 23981126
[TBL] [Abstract][Full Text] [Related]
7. Incidence and predictive factors for positive
Murray IA; Murray LK; Woolson KL; Sherfi H; Dixon I; Palmer J; Sulkin T
Scand J Gastroenterol; 2017; 52(6-7):698-703. PubMed ID: 28276822
[TBL] [Abstract][Full Text] [Related]
8. Methods for diagnosing bile acid malabsorption: a systematic review.
Lyutakov I; Ursini F; Penchev P; Caio G; Carroccio A; Volta U; De Giorgio R
BMC Gastroenterol; 2019 Nov; 19(1):185. PubMed ID: 31726982
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of bile acid diarrhoea by fasting and postprandial measurements of fibroblast growth factor 19.
Borup C; Syversen C; Bouchelouche P; Damgaard M; Graff J; Rumessen JJ; Munck LK
Eur J Gastroenterol Hepatol; 2015 Dec; 27(12):1399-402. PubMed ID: 26426834
[TBL] [Abstract][Full Text] [Related]
10. Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome.
Wedlake L; A'Hern R; Russell D; Thomas K; Walters JR; Andreyev HJ
Aliment Pharmacol Ther; 2009 Oct; 30(7):707-17. PubMed ID: 19570102
[TBL] [Abstract][Full Text] [Related]
11. Effect of colesevelam on faecal bile acids and bowel functions in diarrhoea-predominant irritable bowel syndrome.
Camilleri M; Acosta A; Busciglio I; Boldingh A; Dyer RB; Zinsmeister AR; Lueke A; Gray A; Donato LJ
Aliment Pharmacol Ther; 2015 Mar; 41(5):438-48. PubMed ID: 25594801
[TBL] [Abstract][Full Text] [Related]
12.
Mena Bares LM; Carmona Asenjo E; García Sánchez MV; Moreno Ortega E; Maza Muret FR; Guiote Moreno MV; Santos Bueno AM; Iglesias Flores E; Benítez Cantero JM; Vallejo Casas JA
Rev Esp Med Nucl Imagen Mol; 2017; 36(1):37-47. PubMed ID: 27765536
[TBL] [Abstract][Full Text] [Related]
13. Systematic review with meta-analysis: the prevalence of bile acid malabsorption in the irritable bowel syndrome with diarrhoea.
Slattery SA; Niaz O; Aziz Q; Ford AC; Farmer AD
Aliment Pharmacol Ther; 2015 Jul; 42(1):3-11. PubMed ID: 25913530
[TBL] [Abstract][Full Text] [Related]
14. Serum 7 alpha-hydroxy-4-cholesten-3-one and selenohomocholyltaurine (SeHCAT) whole body retention in the assessment of bile acid induced diarrhoea.
Brydon WG; Nyhlin H; Eastwood MA; Merrick MV
Eur J Gastroenterol Hepatol; 1996 Feb; 8(2):117-23. PubMed ID: 8723414
[TBL] [Abstract][Full Text] [Related]
15. Serum Concentrations of 7α-hydroxy-4-cholesten-3-one Are Associated With Bile Acid Diarrhea in Patients With Crohn's Disease.
Battat R; Duijvestein M; Vande Casteele N; Singh S; Dulai PS; Valasek MA; Mimms L; McFarland J; Hester KD; Renshaw M; Jain A; Sandborn WJ; Boland BS
Clin Gastroenterol Hepatol; 2019 Dec; 17(13):2722-2730.e4. PubMed ID: 30448597
[TBL] [Abstract][Full Text] [Related]
16. Defining primary bile acid diarrhea: making the diagnosis and recognizing the disorder.
Walters JR
Expert Rev Gastroenterol Hepatol; 2010 Oct; 4(5):561-7. PubMed ID: 20932141
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers for Bile Acid Malabsorption in Diarrhea-predominant Irritable Bowel Syndrome: A Systematic Review and Meta-analysis.
Liu T; Ma M; Li K; Tan W; Yu H; Wang L
J Clin Gastroenterol; 2023 May-Jun 01; 57(5):451-458. PubMed ID: 36867517
[TBL] [Abstract][Full Text] [Related]
18. A single faecal bile acid stool test demonstrates potential efficacy in replacing SeHCAT testing for bile acid diarrhoea in selected patients.
Kumar A; Al-Hassi HO; Jain M; Phipps O; Ford C; Gama R; Steed H; Butterworth J; McLaughlin J; Galbraith N; Brookes MJ; Hughes LE
Sci Rep; 2022 May; 12(1):8313. PubMed ID: 35585139
[TBL] [Abstract][Full Text] [Related]
19. [Results of the 75selenium homotaurocholic acid retention test (SeHCAT test) in diagnosis of diarrhea].
Balzer K; Schmitt G; Reiners C; Goebell H
Med Klin (Munich); 1995 Jan; 90(1):27-32. PubMed ID: 7885300
[TBL] [Abstract][Full Text] [Related]
20. Bile acid diarrhoea and FGF19: new views on diagnosis, pathogenesis and therapy.
Walters JR
Nat Rev Gastroenterol Hepatol; 2014 Jul; 11(7):426-34. PubMed ID: 24662279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
